Xencor (XNCR) EBT Margin (2013 - 2026)

Xencor (XNCR) reported EBT Margin of 2848.45% for Q1 2026, down 270099.0% year-over-year from N/an in Q1 2025, and down 18754.12% quarter-over-quarter from 15.11% in Q4 2025.

Xencor (XNCR) EBT Margin (2013 - 2026) Analysis & Trends

Xencor (XNCR) has 14 years of EBT Margin data on file, last reported at 2848.45% in Q1 2026.

  • EBT Margin for Q1 2026 came in at 2848.45%, down 270099.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 174.61% (down 1029.0% YoY), and the FY2025 annual result was 71.38%, up 14124.0% from the prior year.
  • EBT Margin slipped to 2848.45% in Q1 2026 per XNCR's latest filing, from 15.11% in the prior quarter.
  • Over five years, EBT Margin peaked at 30.96% in Q1 2022 and troughed at 2848.45% in Q1 2026.
  • A 5-year average of 286.85% and a median of 84.45% in 2024 frame the typical range for EBT Margin.
  • The sharpest annual moves came in 2025 and 2026: EBT Margin surged 31586 bps in 2025, then tumbled 270099 bps in 2026.
  • A 5-year view of EBT Margin shows it stood at 57.67% in 2022, then jumped by 57 bps to 24.79% in 2023, then plunged by 241 bps to 84.45% in 2024, then jumped by 82 bps to 15.11% in 2025, then slumped by 18754 bps to 2848.45% in 2026.
  • Business Quant data shows XNCR's EBT Margin at 2848.45% in Q1 2026, 15.11% in Q4 2025, and 28.7% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 6.40%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 41.95%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Xencor 953.38 Mn 878.64 Mn - -2,848.45%

Historic Data

Download Data
DateValue
Mar 31, 2026 -2,848.45%
Dec 31, 2025 -15.11%
Sep 30, 2025 -28.70%
Jun 30, 2025 -71.26%
Mar 31, 2025 -147.46%
Dec 31, 2024 -84.45%
Sep 30, 2024 -266.59%
Jun 30, 2024 -287.71%
Mar 31, 2024 -463.31%
Dec 31, 2023 -24.79%
Sep 30, 2023 -41.02%
Jun 30, 2023 -57.12%
Mar 31, 2023 -305.09%
Dec 31, 2022 -57.67%
Sep 30, 2022 -116.01%
Jun 30, 2022 -92.72%
Mar 31, 2022 30.96%
Dec 31, 2021 47.44%
Sep 30, 2021 -204.19%
Jun 30, 2021 13.47%